2017-10-23 SOLOR Dev Meeting notes
Date
Attendees
- Susan Matney
- John Kilbourne
- Holly Miller
- Liz McCool
- Stephanie Klepacki
- Stan Huff
- Avey
- Lindy Buhl (Unlicensed)
- Jay Lyle
- Richard Phillips (Unlicensed)
- Janet Morris
Goals
- SNOMED international meeting update
Discussion items
Time | Item | Who | Notes |
---|---|---|---|
Call meeting to order | Susan Castillo | ||
10min | Update from SNOMED International meeting https://confluence.ihtsdotools.org/pages/viewpage.action?pageId=50594085 discussion with Jim Case about when to submit content | Keith Campbell |
|
Deep Tissue Pressure Injury content request There is an existing concept of Pressure injury of deep tissue (disorder). John would like to discuss how to approach the request. Should he change the associated morphology of the existing concept to represent the new meaning or should a new concept be modeled? | definition from Susan M: Deep Tissue Pressure Injury: Persistent non-blanchable deep red, maroon or purple discoloration Intact or non-intact skin with localized area of persistent non-blanchable deep red, maroon, purple discoloration or epidermal separation revealing a dark wound bed or blood filled blister. Pain and temperature change often precede skin color changes. Discoloration may appear differently in darkly pigmented skin. This injury results from intense and/or prolonged pressure and shear forces at the bone-muscle interface. The wound may evolve rapidly to reveal the actual extent of tissue injury, or may resolve without tissue loss. If necrotic tissue, subcutaneous tissue, granulation tissue, fascia, muscle or other underlying structures are visible, this indicates a full thickness pressure injury (Unstageable, Stage 3 or Stage 4). Do not use DTPI to describe vascular, traumatic, neuropathic, or dermatologic conditions. Susan Castillo make a Jira issue...add pressure injury deep modeling principals...john will model pressure injury of deep tissue differently... | ||
Wound Tissue Color - SOL-22Getting issue details... STATUS
| Liz McCool (Unlicensed) | Stick with red and pink for this round. If SME's come back then we will revisit. SMEs need to provide a definition brightness vs paleness. e.g. what does bright pink mean and what do you do with the data | |
Will need to discuss adding "foreign body" to this refset; we probably need a physical object; what is available now is a finding and a morphology foreign body | John Kilbourne | ||
Keith – Can you have a refset with concepts from different domains? morphology and findings? Does this make it harder for the implementors...? | Susan Matney | Yes, you can have have concepts from different domains in a refset. In Analysis Normal form we want to be more constrained. If the benefits are important to clinical input forms then here is the model. This refset is intended to represent the values needed to populate this particular model. Rather than this refset is general for all uses. The model needs a name and a version. Jay Lyle name and version CIMI model (we can call them a snapshot version for now) for each of these questions SOLOR DEV team will not change any refsets for now with regard to these questions. | |
Associated Clinical Quality Measures<Identify if this refset will be associated with any clinical quality measures> | Susan Castillo | ||
October 30th release of skin wound assessment extension/refsets
| Susan Castillo | At HSPC meeting – define the QA process for Extensions/SOLOR Dev work. |